To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Sodium Valproate and Surgical Mesh Implants
Thursday 14th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her Department's planned timescale is for responding to the Patient Safety Commissioner's report entitled The Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.


Written Question
Visas: Care Workers
Thursday 14th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Home Office:

To ask the Secretary of State for the Home Department, what assessment he has made of the potential implications for his Department's policies of the report by The Bureau of Investigative Journalism entitled Visa system forces care workers to stay silent on rape and abuse, published on 11 March 2024.

Answered by Tom Pursglove - Minister of State (Minister for Legal Migration and Delivery)

The Government strongly condemns any allegations of such abuse.

Anyone who has witnessed or been the victim of criminal activity should, in the first instance, contact the police.

The UK’s sponsorship system has a built-in compliance framework, which has strong safeguards to prevent sponsors from engaging in illegal employment practices.

Sponsors are required to comply with UK laws, including wider employment law (such as working hours and meeting minimum salary requirements). UKVI have powers to revoke a licence where any of the key personnel named on it are convicted of certain serious offences. UKVI regularly visits premises to check sponsor compliance with the duties and requirements set out in the sponsor guidance, and this is frequently done alongside the Gangmasters and Labour Abuse Authority, whose specific remit is to protect vulnerable and exploited workers.

Employers in the health and care sector are also expected to adhere to the Department’s Health and Social Care’s Code of Practice for international recruitment. This sets out clear routes of escalation for anyone with concerns about exploitative recruitment or employment practices. It can be accessed here:

www.gov.uk/government/publications/code-of-practice-for-the-international-recruitment-of-health-and-social-care-personnel/code-of-practice-for-the-international-recruitment-of-health-and-social-care-personnel-in-england.

Anyone who has witnessed or has been the victim of immigration abuse is strongly encouraged to report an immigration or border crime here: www.gov.uk/report-immigration-crime.

Or, to the Gangmasters & Labour Abuse Authority (GLAA) here: www.gla.gov.uk/report-issues/.


Written Question
Triamcinolone Hexacetonide
Tuesday 12th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the adequacy of the supply of triamcinolone hexacetonide injections (intra-articular steroid) for children and young people with rheumatoid arthritis.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

We are aware of a shortage of triamcinolone hexacetonide 20 milligram/1 millilitre suspension for injection ampoules. Details of this shortage were shared with the National Health Service in June 2022. We are working closely with the sole supplier of this product to expedite resupplies, to make this important product is available again as soon as possible. We regularly review the tier, or impact categorisation, assigned to supply issues, and the tier of a supply issue does not affect the options available for management.

We understand how frustrating and distressing medicine supply issues can be. While we cannot always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise. We work with the pharmaceutical industry, NHS England, the devolved administrations, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help prevent shortages, and to ensure that the risks to patients are minimised when supply issues arise. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.


Written Question
Triamcinolone Hexacetonide
Tuesday 12th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether her Department plans to review the impact categorisation of the supply shortage of triamcinolone hexacetonide injections (intra-articular steroid).

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

We are aware of a shortage of triamcinolone hexacetonide 20 milligram/1 millilitre suspension for injection ampoules. Details of this shortage were shared with the National Health Service in June 2022. We are working closely with the sole supplier of this product to expedite resupplies, to make this important product is available again as soon as possible. We regularly review the tier, or impact categorisation, assigned to supply issues, and the tier of a supply issue does not affect the options available for management.

We understand how frustrating and distressing medicine supply issues can be. While we cannot always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise. We work with the pharmaceutical industry, NHS England, the devolved administrations, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help prevent shortages, and to ensure that the risks to patients are minimised when supply issues arise. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.


Written Question
UNRWA: Finance
Tuesday 12th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State, Foreign, Commonwealth and Development Office, if he will make an assessment of the potential implications for his policies of the joint NGO statement entitled EU and Member States must sustain funding to UNRWA, published on 29 February 2024.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

We are appalled by allegations that the United Nations Relief and Works Agency (UNRWA) staff were involved in the 7 October attack against Israel, a heinous act of terrorism that the UK Government has repeatedly condemned.

As we have set out, we are pressing the UN Office of Internal Oversight and Catherine Colonna, who is leading the independent Review Group appointed by the UN Secretary-General, to produce a rapid interim report. We want UNRWA to give detailed undertakings about changes in personnel, policy and precedents to ensure this can never happen again. We are working with allies to try to bring this situation to a rapid conclusion not least because UNRWA have a vital role to play in providing aid and services in Gaza.

Our decision to pause future funding to UNRWA has no impact on the UK's contribution to the current humanitarian response. We have trebled our aid commitment this financial year and we are doing everything we can to get more aid in and open more crossings. We are providing £60 million in humanitarian assistance to support partners including the British Red Cross, UNICEF, the UN World Food Programme (WFP) and Egyptian Red Crescent Society to respond to critical food, fuel, water, health, shelter and security needs in Gaza.

We are aware of the NGO statement referred to by the Member for Liverpool, Walton.


Written Question
UN Security Council: Reform
Tuesday 12th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State, Foreign, Commonwealth and Development Office, with reference to the UN Meetings Coverage reports GA/12563, published on 17 November 2023, and GA/12586, published on 5 March 2024, what assessment he has made of the potential merits of proposals to reform the UN Security Council to limit the power of veto.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

As a permanent member of the Security Council, we consider the veto a heavy responsibility, to be used in the interests of securing international peace and security.

We support responsible and accountable use of the veto. The UK Government was proud to co-sponsor the Veto Initiative that enables the General Assembly to scrutinise use of the veto. We support the Accountability, Coherence and Transparency code of conduct, through which we have committed not to vote against a credible draft resolution to prevent or end a mass atrocity. The UK has not used its veto since 1989.


Written Question
Gaza: Babies
Tuesday 12th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State, Foreign, Commonwealth and Development Office, with reference to the statement by UNICEF of 3 March 2024, what assessment he has made of the implications for his Department's policies of reports that infants in Gaza are dying from (a) dehydration and (b) malnutrition.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

We are directly funding UNICEF and the Red Cross to provide vital support for children's health in Gaza and the Occupied Palestinian Territories, including mental health services, medical care, essential supplies, food security, nutrition, clean water, shelter and other humanitarian assistance. For UNICEF specifically, we have provided targeted support for children through a £5.75 million contribution, part of our wider £60 million humanitarian uplift. This is supporting their work to assist over 5,800 children with severe malnourishment. The UK has also supported the United Nations World Food Programme to deliver a new humanitarian land corridor from Jordan into Gaza. 750 tonnes of life-saving food aid arrived in the first delivery in December and there have been numerous deliveries since.

Israel must take steps, working with other partners including the UN and Egypt, to significantly increase the flow of aid into Gaza including allowing prolonged humanitarian pauses, opening more routes into Gaza and restoring and sustaining water, fuel and electricity. We have reiterated the need for Israel to open more crossing points into Gaza, for Nitzana and Kerem Shalom to be open for longer, and for Israel to support the UN to distribute aid effectively across the whole of Gaza. We continue to raise this with Israel at the highest levels.


Written Question
Gender Based Violence: Prosecutions
Monday 11th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Attorney General:

To ask the Attorney General, what steps she is taking to increase prosecution rates for cases relating to violence against women and girls.

Answered by Robert Courts - Solicitor General (Attorney General's Office)

Tackling violence against women and girls (VAWG) remains one of this government’s top priorities. We continue to expand the number of VAWG offences to reflect the evolving criminal justice landscape.

The Crown Prosecution Service (CPS) is improving the way existing offences are prosecuted. It has produced a new operating model for the prosecution of rape and is now working in partnership with the police on a joint action plan to improve their collective handling of domestic abuse cases, applying the same principles from the work on rape which has driven marked improvement.

To address the increasing complexity of VAWG offending, and the holistic needs of victims, the CPS is also producing a new VAWG strategy which will be published by Autumn 2024.


Written Question
Health: Disadvantaged
Monday 11th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the implications for her Department’s policies of a call from over 250 members of the Inequalities in Health Alliance (IHA) for a cross-government strategy to reduce health inequalities.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to its levelling up mission to narrow the gap in healthy life expectancy by 2030, and increase healthy life expectancy by five years, by 2035. We are supporting people in living healthier lives, helping the National Health Service and social care provide the best treatment and care for patients, and tackling health disparities through national and system interventions such as the NHS’s Core20PLUS5 programme.

The Government continues to work together, through the Department for Levelling Up, Housing and Communities (DLUHC)-led Levelling Up Inter-Ministerial Group, to progress the wider levelling up agenda. The levelling up missions are mutually reinforcing, and we are exploring new and existing opportunities for cross-Government action on the drivers of health, to support progress on the health mission and our wider common interests.

We are also working with the DLUHC to maximise opportunities to develop partnerships through English devolution and the Levelling Up Partnerships programme. These provide opportunities to test what works at a local and regional level, to support the health mission.


Written Question
Health: Disadvantaged
Monday 11th March 2024

Asked by: Dan Carden (Labour - Liverpool, Walton)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of establishing a cross-government strategy to tackle health inequalities.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to its levelling up mission to narrow the gap in healthy life expectancy by 2030, and increase healthy life expectancy by five years, by 2035. We are supporting people in living healthier lives, helping the National Health Service and social care provide the best treatment and care for patients, and tackling health disparities through national and system interventions such as the NHS’s Core20PLUS5 programme.

The Government continues to work together, through the Department for Levelling Up, Housing and Communities (DLUHC)-led Levelling Up Inter-Ministerial Group, to progress the wider levelling up agenda. The levelling up missions are mutually reinforcing, and we are exploring new and existing opportunities for cross-Government action on the drivers of health, to support progress on the health mission and our wider common interests.

We are also working with the DLUHC to maximise opportunities to develop partnerships through English devolution and the Levelling Up Partnerships programme. These provide opportunities to test what works at a local and regional level, to support the health mission.